The regulation of VEGF through other mechanisms has also been explored in NSCLC as p53 and Bcl2 were significantly associated with VEGF expression; however, a recent study demonstrated no difference in survival regarding the Bcl2 and VEGF statuses for patients with advanced NSCLC despite the identified correlation [72,73]. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.